The 10 Highest Yielding Preferred Stocks
By Preferred Stock Channel Staff, updated Tue, March 19, 3:32 AM
#10 . Fortress Biotech Inc | 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:FBIOP ) | 14.25% CURRENT YIELD
Discount to Liquidation Preference: -34.20% Average Premium in Category: 12.59%
Current Annualized Yield: 14.25% Average Yield in Category: 8.61% Days Since Last Ex-Div Date: 1 | See Dividend History » Categorization: Drugs & Pharmaceuticals
Series: A Redeemable?: Yes Call Date: 12/15/2022 (Now Trading Post Call Date) Perpetual?: Yes Cumulative?: Yes Shares Offered: 1,000,000 Overallotment: 150,000 Liquidation Preference: $25.00 Recent Market Price: $16.36 Discount to Liquidation Preference:(More Preferreds Trading at a Discount » ) $-8.64 (-34.56%) Annualized Dividend: 2.343756 Recent Ex-Date: 3/14/2024 Current Yield: 14.33% Original Coupon: 9.38% Pay Period: Quarterly Pay Dates: 31-Mar, 30-Jun, 30-Sep, 31-Dec CDx3 Compliance Rating:
Learn FBIOP's Rating
Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets dermatology products including Qbrexza®, which is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane® (isotretinoin) capsule, which is an oral capsule for the treatment of severe recalcitrant nodular acne; Ximino® (minocycline hydrochloride), which is an oral minocycline drug for the treatment of moderate to severe acne; as well as Targadox® (doxycycline hyclate), which is an oral doxycycline drug for adjunctive therapy for severe acne. Preferred: FBIOP
Open the FBIO Information Page »
The 10 Highest Yielding Preferred Stocks - Slide 1 of 10 | www.PreferredStockChannel.com
Copyright © 2010 - 2024, All Rights Reserved
Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use
and Privacy Policy . Video widget and videos powered by Market News Video . Quote data delayed at least 20
minutes; data powered by Ticker Technologies , and Mergent . Contact Preferred Stock Channel ; Meet Our Editorial Staff .